Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations.
$1.51+11.03%
报价 2026-11-13
市值
$115M
EV
$229M
PE (TTM)
–
预期 PE (FY2026)
27.9x
52 周区间距高点 -49.5%
$1.00$2.99
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| HCATHealth Catalyst, Inc. | $115M | +11.0% | -13.6% | 46.4% | – | – | 9.2x | |
| OBIOOrchestra BioMed Holdings, Inc. | $570.6M | +17.9% | -85.7% | 99.3% | – | – | – | |
| ENTAEnanta Pharmaceuticals, Inc. | $320.1M | -1.9% | -6.6% | 100% | – | – | – | |
| PRLDPrelude Therapeutics Incorporated | $199.7M | -2.0% | +56.0% | 98.3% | – | – | – | |
| PYXSPyxis Oncology, Inc. | $189M | -3.7% | -100.0% | 99.8% | – | – | – | |
| HSDTTessera Defense and Homeland Security Inc | $101M | -8.5% | +3075.0% | 95.5% | – | – | – | |
| TNYATenaya Therapeutics, Inc. | $79.6M | +0.5% | +304.8% | 116.1% | – | – | – | |
| OMOutset Medical, Inc. | $70.3M | -3.4% | +8.0% | 41.8% | – | – | – | |
| CRBUCaribou Biosciences, Inc. | $39.1M | -4.8% | +151.1% | -129.7% | – | – | – | |
| 同行中位数 | – | – | +32.0% | 98.8% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。